QNCX
Quince Therapeutics Inc.
$1.96
+$0.09(+4.81%)
50
Overall
--
Value
75
Tech
26
Quality
Market Cap
$85.94M
Volume
333.81K
52W Range
$0.71 - $2.45
Target Price
$7.40
Key Metrics Overview
| Market Cap | $85.94M | P/E Ratio | N/A |
| 52W High | $2.45 | 52W Low | $0.71 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | N/A | 52W Position | 71.8% |
| Overall Score | 50 | Value Score | -- |
| Quality Score | 26 | Technical Score | 75 |
Growth Analysis
| EPS Current Est | $-1.07 | EPS Next Est | $-0.66 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | QNCX | $1.96 | +4.8% | 333.81K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Quince Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW